HOPE — Execution
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
HOPE — Human Organs, Physiology, and Engineering — is a $50 million Wellcome Leap program focused on engineering human tissues and organs for two primary applications: creating a multiorgan platform that replicates human immune responses for drug testing, and advancing bioengineered kidney technology to improve survival outcomes for patients with end-stage renal disease. The program is led by Prog…
Human tissue, organoid, and bioengineered organ development for drug testing and end-stage renal disease treatment, through academic, foundation, and private-sector collaboration.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility